News Quantified

CRNX – crinetics pharmaceuticals, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $87.00 price target on the stock.

Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer [Yahoo! Finance]

Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer

Crinetics Pharmaceuticals Announces December 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients with Acromegaly

0.2%

MISS

-6.1%

MISS

-1.8%

MISS

-4.3%

MISS

Market Outperform

Market Outperform

Market Outperform

Market Outperform

Market Outperform

Market Outperform

Market Outperform

Market Outperform

Form 4 Crinetics Pharmaceutical For: Dec 16 Filed by: Betz Stephen F.

Form 8-K Crinetics Pharmaceutical For: Dec 16

Form 8-K Crinetics Pharmaceutical For: Dec 09

Form 4 Crinetics Pharmaceutical For: Dec 02 Filed by: Struthers Richard Scott

Form 144 Crinetics Pharmaceutical Filed by: Struthers Richard Scott

Top News Gainers

3/16 Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 15.3%

4/4 Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $35.00 price target on the stock. 11.0%

4/14 Form 424B5 Crinetics Pharmaceutical 7.6%

9/25 Crinetics Pharmaceuticals to Participate in Cantor Global Healthcare Conference 6.3%

1/8 Crinetics Pharmaceuticals to Present at J.P. Morgan Healthcare Conference 5.6%

8/7 Form 4 Crinetics Pharmaceutical For: Aug 05 Filed by: Struthers Richard Scott 5.5%

4/20 Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 5.5%

3/4 Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 4.9%

3/27 Form 3 Crinetics Pharmaceutical For: Mar 20 Filed by: Madan Ajay 4.1%

11/26 Crinetics Pharmaceuticals to Participate in the Piper Jaffray Healthcare Conference 4.1%

Top News Decliners

3/11 Form 4 Crinetics Pharmaceutical For: Mar 09 Filed by: Vivo Opportunity, LLC -14.9%

4/6 Crinetics Pharmaceuticals Reports Positive Interim Results for the ACROBAT Edge Phase 2 Trial of Paltusotine (CRN00808) in Acromegaly Patients and Provides Corporate Update -10.9%

3/9 Q4/2019 12/31/2019 EPS -0.600 ZacksConsensus -0.670 ActVsEst 0.070 - Beat -9.4%

8/13 Q2/2019 6/30/2019 EPS -0.510 ZacksConsensus N/A ActVsEst N/A - N/A -7.2%

7/29 Crinetics Pharmaceuticals to Receive Final Award of SBIR Grant from NIH for Congenital Hyperinsulinism -5.7%

4/23 Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.1%

2/25 Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) was downgraded by analysts at TheStreet from a "c-" rating to a "d" rating. -4.3%

1/11 Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) was upgraded by analysts at TheStreet from a "d" rating to a "c-" rating. -3.5%

2/26 Form 4 Crinetics Pharmaceutical For: Feb 24 Filed by: Struthers Richard Scott -3.2%

2/6 Form SC 13G/A Crinetics Pharmaceutical Filed by: 5AM Ventures IV, L.P. -2.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day